Faron Pharmaceuticals Oy Notification of Major Interest in Shares (8079L)
06 October 2016 - 3:10AM
UK Regulatory
TIDMFARN TIDMAV.
RNS Number : 8079L
Faron Pharmaceuticals Oy
05 October 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
----------------------------------------------------------------------------------------------------
1. Identity of the issuer or Faron Pharmaceuticals Oy
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
--------------------------------------------------------------- -----------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
----------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
------------------------------------------------------------------ --------------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
------------------------------------------------------------------ --------------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
------------------------------------------------------------------ --------------------------------
An event changing the breakdown of voting rights
------------------------------------------------------------------ --------------------------------
Other (please
specify):
----------------------------------------------------------- ----- --------------------------------
3. Full name of person(s) Aviva plc & its subsidiaries
subject to the
notification obligation:
(iii)
------------------------------------------------------------- -------------------------------------
4. Full name of shareholder(s) Registered Holder:
(if different from 3.):(iv)
BNY Norwich Union Nominees
Limited 122,189*
Chase (GA Group) Nominees
Limited 1,697,607*
State Street Nominees Limited
319,947*
* denotes direct interest
Chase (GA Group) Nominees
Limited 79,797
Chase Nominees Limited 52,129
------------------------------------------------------------- -------------------------------------
5. Date of the transaction 03 October 2016
and date on
which the threshold is
crossed or
reached: (v)
------------------------------------------------------------- -------------------------------------
6. Date on which issuer 04 October 2016
notified:
------------------------------------------------------------- -------------------------------------
7. Threshold(s) that is/are 9% to 8% Change at Combined
crossed or Interest Level. Figures are
reached: (vi, vii) provided in accordance with
provisions of your company
articles and not in fulfilment
of the requirements of the
Transparency Directive.
------------------------------------------------------------- -------------------------------------
8. Notified details:
--------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
--------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
---------------- --------------------------------- ---------------------------------------------------------
Number Number Number Number of % of voting
of of of shares voting rights (x)
Shares Voting rights
Rights
---------------- ----------------- -------------- ------------ ---------------------- -------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
---------------- ---------------- ------------- ------------ ---------- ---------- ------- ----------
Ordinary 2,305,769 2,305,769
Shares As per As per
last last
TR-1 TR-1
FI4000153309 Disclosure Disclosure 2,271,669 2,139,743 131,926 8.13% 0.50%
----------------- -------------- ------------ ---------- ---------- ------- ----------
B: Qualifying Financial Instruments
--------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
--------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument (xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
----------------- ----------------- --------------------------- ---------------------- -------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
-----------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-----------------------------------------------------------------------------------------------
Type of financial Exercise Expiration Exercise/ Number of voting % of voting
instrument price date Conversion rights instrument rights (xix,
(xvii) period refers to xx)
(xviii)
------------------ --------- ----------- ------------ ------------------- ----------------
Nominal Delta
------------------ --------- ----------- ------------ ------------------- -------- ------
Total (A+B+C)
-----------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
-------------------------------------------------------- -------------------------------------
2,271,669 8.63%
-------------------------------------------------------- -------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
--------------------------------------------------------------------
The voting rights are managed and controlled by Aviva
Investors Global Services Limited, with the following
chains of controlled undertakings:-
Aviva Investors Global Services Limited:
* Aviva plc (Parent Company)
* Aviva Group Holdings Limited (wholly owned subsidiary
of Aviva plc)
* Aviva Investors Holdings Limited (wholly owned
subsidiary of Aviva Group Holdings Limited)
* Aviva Investors Global Services Limited (wholly owned
subsidiary of Aviva Investors Holdings Limited)
Proxy Voting:
--------------------------------------------------------------------
10. Name of the proxy holder: See Section 4
------------------------------------------------ ------------------
11. Number of voting rights proxy
holder will cease
to hold:
------------------------------------------------ ------------------
12. Date on which proxy holder will
cease to hold
voting rights:
------------------------------------------------ ------------------
13. Additional information: Figures are based on a total
number of voting rights of
26,311,704 as per the Company's
Results of Placing and Subscription,
Issue of Equity and Director/PDMR
Shareholding Announcement
of
21 September 2016.
------------------------------- --------------------------------------
14. Contact name: Neil Whittaker, Aviva plc
------------------------------- --------------------------------------
15. Contact telephone number: 00 44 1603 684420
------------------------------- --------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLBUBDGDGGBGLU
(END) Dow Jones Newswires
October 05, 2016 12:10 ET (16:10 GMT)
Faron Pharmaceuticals Oy (LSE:FARN)
Historical Stock Chart
From Apr 2024 to May 2024
Faron Pharmaceuticals Oy (LSE:FARN)
Historical Stock Chart
From May 2023 to May 2024
